These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 1904554)

  • 1. New use of BCG for recombinant vaccines.
    Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
    Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
    Fuerst TR; Stover CK; de la Cruz VF
    Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A; Young RA
    Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity elicited by rBCG vaccines.
    Stover CK; Bansal GP; Langerman S; Hanson MS
    Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
    Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
    Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant BCG as an antigen delivery system.
    Flynn JL
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
    Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
    DasGupta SK; Jain S; Kaushal D; Tyagi AK
    Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
    Dennehy M; Bourn W; Steele D; Williamson AL
    Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
    Dai W; Huangfu Y; Zheng B
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys.
    Yasutomi Y; Koenig S; Haun SS; Stover CK; Jackson RK; Conard P; Conley AJ; Emini EA; Fuerst TR; Letvin NL
    J Immunol; 1993 Apr; 150(7):3101-7. PubMed ID: 8454878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of live recombinant BCG vaccines.
    Hanson MS; Bansal GP; Langermann S; Stover CK; Orme I
    Dev Biol Stand; 1995; 84():229-36. PubMed ID: 7796958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
    Oliveira TL; Rizzi C; Dellagostin OA
    Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens.
    Rezende CA; De Moraes MT; De Souza Matos DC; McIntoch D; Armoa GR
    J Virol Methods; 2005 Apr; 125(1):1-9. PubMed ID: 15737410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.